Stay updated on Adjuvant Nivolumab for Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    0.7%
    Check dated 2026-10-25T04:00:01.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-18T03:25:04.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T06:42:35.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    An updated revision entry v3.7.0 has been added to the study record history. The previous revision v3.6.6 has been removed, indicating the history now reflects the latest versioning of the record.
    Difference
    0.1%
    Check dated 2026-09-20T02:10:00.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    A new Revision: v3.6.6 entry was added to the history and the previous Revision: v3.6.5 entry was removed, indicating a version update of the page.
    Difference
    0.1%
    Check dated 2026-08-29T23:44:07.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision history now shows the latest release as v3.6.5, replacing v3.6.4. This reflects a site update rather than changes to study data or page content.
    Difference
    0.1%
    Check dated 2026-08-08T18:46:05.000Z thumbnail image

Stay in the know with updates to Adjuvant Nivolumab for Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.